Cargando…

Evaluation of Circulating Tumor DNA in Patients with Ovarian Cancer Harboring Somatic PIK3CA or KRAS Mutations

PURPOSE: Circulating tumor DNA (ctDNA) is an attractive source for liquid biopsy to understand molecular phenotypes of a tumor non-invasively, which is also expected to be both a diagnostic and prognostic marker. PIK3CA and KRAS are among the most frequently mutated genes in epithelial ovarian cance...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ogasawara, Aiko, Hihara, Taro, Shintani, Daisuke, Yabuno, Akira, Ikeda, Yuji, Tai, Kenji, Fujiwara, Keiichi, Watanabe, Keisuke, Hasegawa, Kosei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Cancer Association 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7577815/ https://www.ncbi.nlm.nih.gov/pubmed/32599986 http://dx.doi.org/10.4143/crt.2019.688

Ejemplares similares

High expression of maternal embryonic leucine-zipper kinase (MELK) impacts clinical outcomes in patients with ovarian cancer and its inhibition suppresses ovarian cancer cells growth ex vivo
por: Ikeda, Yuji, et al.
Publicado: (2020)

A pilot study of mobile digital colposcopy in Japanese patients with cervical intraepithelial neoplasm
por: Sato, Masakazu, et al.
Publicado: (2021)

Clinical significance of metabolism-related genes and FAK activity in ovarian high-grade serous carcinoma
por: Sato, Masakazu, et al.
Publicado: (2022)

EGFR, PIK3CA, KRAS and BRAF mutations in meningiomas
por: BUJKO, MATEUSZ, et al.
Publicado: (2014)

Association between effector-type regulatory T cells and immune checkpoint expression on CD8(+) T cells in malignant ascites from epithelial ovarian cancer
por: Sato, Sho, et al.
Publicado: (2022)

The prognostic role of KRAS, BRAF, PIK3CA and PTEN in colorectal cancer
por: Eklöf, V, et al.
Publicado: (2013)

Prevalence of KRAS, BRAF, and PIK3CA somatic mutations in patients with colorectal carcinoma may vary in the same population: clues from Sardinia
por: Palomba, Grazia, et al.
Publicado: (2012)

Somatic gain-of-function mutations in PIK3CA in patients with macrodactyly
por: Rios, Jonathan J., et al.
Publicado: (2013)

Frequency and spectrum of PIK3CA somatic mutations in breast cancer
por: Martínez-Sáez, Olga, et al.
Publicado: (2020)

Characterization of PIK3CA and PIK3R1 somatic mutations in Chinese breast cancer patients
por: Chen, Li, et al.
Publicado: (2018)

KRAS, BRAF and PIK3CA Status in Squamous Cell Anal Carcinoma (SCAC)
por: Casadei Gardini, Andrea, et al.
Publicado: (2014)

Mutation patterns and prognostic analysis of BRAF/KRAS/PIK3CA in colorectal cancer
por: Wang, Chengfeng, et al.
Publicado: (2022)

Coexistence of EGFR with KRAS, or BRAF, or PIK3CA somatic mutations in lung cancer: a comprehensive mutation profiling from 5125 Chinese cohorts
por: Li, S, et al.
Publicado: (2014)

Somatic activating mutations in PIK3CA cause generalized lymphatic anomaly
por: Rodriguez-Laguna, Lara, et al.
Publicado: (2019)

Somatic mutation in PIK3CA is a late event in cervical carcinogenesis
por: Verlaat, Wina, et al.
Publicado: (2015)

PIK3CA and KRAS Amplification in Esophageal Adenocarcinoma and their Impact on the Inflammatory Tumor Microenvironment and Prognosis
por: Essakly, Ahlem, et al.
Publicado: (2019)

Identification of serum cytokine clusters associated with outcomes in ovarian clear cell carcinoma
por: Yabuno, Akira, et al.
Publicado: (2020)

A girl with CLOVES syndrome with a recurrent PIK3CA somatic mutation and pancreatic steatosis
por: Hanafusa, Hiroaki, et al.
Publicado: (2019)

High resolution melting analysis of KRAS, BRAF and PIK3CA in KRAS exon 2 wild-type metastatic colorectal cancer
por: Guedes, Joana G, et al.
Publicado: (2013)

Somatic mutation and gain of copy number of PIK3CA in human breast cancer
por: Wu, Guojun, et al.
Publicado: (2005)

Cerebrofacial vascular metameric syndrome is caused by somatic pathogenic variants in PIK3CA
por: Sheppard, Sarah E., et al.
Publicado: (2021)

KRAS, BRAF and PIK3CA Mutations and the Loss of PTEN Expression in Chinese Patients with Colorectal Cancer
por: Mao, Chen, et al.
Publicado: (2012)

BRAF, KRAS and PIK3CA Mutation and Sensitivity to Trastuzumab in Breast Cancer Cell Line Model
por: Patra, Satyajit, et al.
Publicado: (2017)

Prognostic value of KRAS/TP53/PIK3CA in non-small cell lung cancer
por: Zhao, Jiayi, et al.
Publicado: (2019)

BRAF, KRAS and PIK3CA Mutation and Sensitivity to Trastuzumab in Breast Cancer Cell Line Model
por: Dirican, Ebubekir
Publicado: (2020)

Pazopanib as a second line treatment for uterine and ovarian carcinosarcoma: a single institutional study
por: Nishikawa, Tadaaki, et al.
Publicado: (2017)

Clinicopathological features and prognostic roles of KRAS, BRAF, PIK3CA and NRAS mutations in advanced gastric cancer
por: Takahashi, Naoki, et al.
Publicado: (2014)

Comparison of KRAS and PIK3CA gene status between primary tumors and paired metastases in colorectal cancer
por: He, Qiong, et al.
Publicado: (2016)

Mutations of KRAS, NRAS, BRAF, EGFR, and PIK3CA genes in urachal carcinoma: Occurence and prognostic significance
por: Módos, Orsolya, et al.
Publicado: (2016)

EGFR, KRAS, BRAF, PTEN, and PIK3CA mutation in plasma of small cell lung cancer patients
por: Lu, Hong-Yang, et al.
Publicado: (2018)

Clinical Impact and Prognostic Role of KRAS/BRAF/PIK3CA Mutations in Stage I Colorectal Cancer
por: Reggiani Bonetti, Luca, et al.
Publicado: (2018)

Targeting β-catenin overcomes MEK inhibition resistance in colon cancer with KRAS and PIK3CA mutations
por: Moon, Jai-Hee, et al.
Publicado: (2019)

PIK3CA Cooperates with KRAS to Promote MYC Activity and Tumorigenesis via the Bromodomain Protein BRD9
por: Bell, Catherine M., et al.
Publicado: (2019)

Carcinogenesis of PIK3CA
por: German, Sidra, et al.
Publicado: (2013)

mTOR Co-Targeting in Cetuximab Resistance in Head and Neck Cancers Harboring PIK3CA and RAS Mutations
por: Wang, Zhiyong, et al.
Publicado: (2014)

Somatic non-cancerous PIK3CA-related overgrowth syndrome treated with alpelisib in North America
por: Garneau, Alexandre P., et al.
Publicado: (2021)

Case Report of Fibro-Adipose Vascular Anomaly (FAVA) with Activating Somatic PIK3CA Mutation
por: Driskill, Jordan H., et al.
Publicado: (2022)

Multiple congenital malformations arise from somatic mosaicism for constitutively active Pik3ca signaling
por: Marechal, Elise, et al.
Publicado: (2022)

Case report: PIK3CA somatic mutation leading to Klippel Trenaunay Syndrome and multiple tumors
por: Serio, Viola Bianca, et al.
Publicado: (2023)

FGFR3, HRAS, KRAS, NRAS and PIK3CA Mutations in Bladder Cancer and Their Potential as Biomarkers for Surveillance and Therapy
por: Kompier, Lucie C., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_1rua8386nol9k0ptqv4oele4l3